DILATREND TABLET 6.25 mg

Страна: Сінгапур

мова: англійська

Джерело: HSA (Health Sciences Authority)

Активний інгредієнт:

CARVEDILOL

Доступна з:

ROCHE SINGAPORE PTE. LTD.

Код атс:

C07AG02

Дозування:

6.25 mg

Фармацевтична форма:

TABLET

Адміністрація маршрут:

ORAL

Тип рецепту:

Prescription Only

Виробник:

ROCHE SPA

Дата Авторизація:

1998-10-30

інформаційний буклет

KOEPCKE.PUBLISHING
DRAFT (DATE) 24.05.2018 [13:30 uhr] (2)
COLOURS pantone black
DIMENSIONS 210 x 600 mm
MATERIAL NUMBER 90001794/10 local
FONT SIZE 7,5 pt
DILATREND
®
Carvedilol
ALPHA (Α) AND BETA (Β) ADRENERGIC RECEPTOR BLOCKING AGENTS
1. DESCRIPTION
1.1 THERAPEUTIC/PHARMACOLOGIC CLASS OF DRUG
Alpha (α) and beta (β) adrenergic receptor blocking agents
ATC CODE: C07AG02
1.2 TYPE OF DOSAGE FORM
Tablets
The tablets are uncoated, round, and biconvex with a bilateral
scoreline, and either
pale pink (3.125 mg), yellow (6.25 mg), pale peach (12.5 mg) or white
(25 mg).
1.3 ROUTE OF ADMINISTRATION
Oral.
1.4 STERILE/RADIOACTIVE STATEMENT
Not applicable.
1.5 QUALITATIVE AND QUANTITATIVE COMPOSITION
_Active ingredient:_ carvedilol.
Tablets
One 3.125 mg tablet contains 3.125 mg carvedilol.
One 6.25 mg tablet contains 6.25 mg carvedilol.
One 12.5 mg tablet contains 12.5 mg carvedilol.
One 25 mg tablet contains 25 mg carvedilol.
2. CLINICAL PARTICULARS
2.1 THERAPEUTIC INDICATION(S)
_Hypertension_
Dilatrend is indicated for the management of essential hypertension.
It can be used alone or in combination with other antihypertensive
agents (e.g.
calcium channel blockers, diuretics).
_Treatment of angina pectoris_
_Treatment of symptomatic chronic heart failure_
Dilatrend is indicated for the treatment of symptomatic chronic heart
failure (CHF)
to reduce mortality and cardiovascular hospitalisations, improve
patient well-being
and slow the progression of the disease.
Dilatrend may be used as adjunct to standard therapy, but may also be
used in those
patients unable to tolerate an ACE inhibitor, or those who are not
receiving digitalis,
hydralazine or nitrate therapy.
2.2 DOSAGE AND ADMINISTRATION
_Method of administration_
The tablets are to be swallowed with sufficient fluid.
_Duration of treatment_
Treatment with carvedilol is a long-term therapy. As with all
β-blockers, treatment
should not be stopped abruptly but rather gradually reduced at weekly
intervals.
This is particularly important in the case of patients with
co